Dragonfly Therapeutics, Inc. has licensed two TriNKET immunotherapy drug candidates to Celgene Corp. and its affiliates for $12 million each plus milestones and royalties.
Genentech is the latest biopharma company to be involved in an industrial espionage case, with three former researchers accused of passing sensitive information to a foreign rival.
Intellectual Property (IP) could be considered the foundation for pharmaceutical innovation. In healthcare, innovation means improved health outcomes: avoiding illness; slowing disease progression; improving patients’ lives; and reducing overall costs for